Studio Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.93M Buy
21,295
+2,368
+13% +$217K 0.35% 56
2025
Q4
$1.71M Sell
18,927
-264
-1% -$25K 0.31% 56
2025
Q3
$1.89M Buy
19,191
+806
+4% +$79.9K 0.36% 53
2025
Q2
$1.68M Buy
18,385
+213
+1% +$20.6K 0.34% 56
2025
Q1
$2.06M Buy
18,172
+208
+1% +$22.3K 0.43% 50
2024
Q4
$1.9M Buy
17,964
+591
+3% +$63.4K 0.4% 59
2024
Q3
$1.88M Buy
17,373
+5,953
+52% +$650K 0.4% 59
2024
Q2
$1.24M Sell
11,420
-188
-2% -$22.2K 0.28% 65
2024
Q1
$1.53M Sell
11,608
-412
-3% -$51.5K 0.36% 61
2023
Q4
$1.46M Buy
12,020
+1,785
+17% +$199K 0.37% 65
2023
Q3
$1.15M Sell
10,235
-2,840
-22% -$361K 0.32% 64
2023
Q2
$1.91M Sell
13,075
-1,817
-12% -$247K 0.53% 52
2023
Q1
$1.93M Sell
14,892
-876
-6% -$110K 0.58% 48
2022
Q4
$2.01M Sell
15,768
-242
-2% -$28.1K 0.65% 46
2022
Q3
$1.67M Buy
16,010
+465
+3% +$51K 0.6% 51
2022
Q2
$1.63M Sell
15,545
-30
-0.2% -$3.56K 0.57% 54
2022
Q1
$1.99M Buy
15,575
+1,382
+10% +$167K 0.66% 54
2021
Q4
$1.75M Buy
14,193
+664
+5% +$86.9K 0.63% 57
2021
Q3
$1.92M Buy
+13,529
New +$1.99M 0.82% 40

Other funds holding ZBH

Studio Investment Management's ZBH Position: Q1 2026 in Review

Studio Investment Management increased its Zimmer Biomet (ZBH) stake by 13% in Q1 2026, buying an estimated $217K and bringing the position to 21,295 shares worth $1.93M. The position accounts for 0.35% of the portfolio, ranked #56.

Studio Investment Management first reported a position in ZBH in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.06M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Studio Investment Management held 21,295 shares of Zimmer Biomet worth $1.93M as of Q1 2026.
  • Studio Investment Management bought 2,368 Zimmer Biomet shares in Q1 2026, an estimated $217K.
  • Zimmer Biomet made up 0.35% of Studio Investment Management's portfolio in Q1 2026, its #56 holding.
  • Studio Investment Management first reported a position in Zimmer Biomet in Q3 2021 and has held it in 19 quarters since.
  • Studio Investment Management's Zimmer Biomet position peaked at $2.06M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Studio Investment Management's 13F filing for Q1 2026, filed 5 May 2026.